We suggest that KD, Ketone supplements, and BHB formulation are most likely to have an impact on this earliest MCI phase of human AD, and could potentially extend/rescue this phase in humans, as KD/BHB appears to rescue MCI in APP/PS1 mice. This evidence concerns the gene APP and Alzheimer disease.